Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
JAMA Network Open|August 26, 2021
Association Between Human Papillomavirus Vaccination and Primary Ovarian Insufficiency in a Nationwide CohortAnders Hviid, Emilia Myrup Thiesson
Annals of Internal Medicine|February 1, 2022
Association of AZD1222 and BNT162b2 COVID-19 Vaccination With Thromboembolic and Thrombocytopenic Events in Frontline Personnel : A Retrospective Cohort StudyAnders Hviid, Jørgen Vinsløv Hansen, Emilia Myrup Thiesson, et al.
BMJ (Clinical Research Ed.)|July 25, 2023
Safety of BA.4-5 or BA.1 bivalent mRNA booster vaccines: nationwide cohort studyNiklas Worm Andersson, Emilia Myrup Thiesson, Jørgen Vinsløv Hansen, et al.
Contact Dermatitis|December 7, 2023
Association between atopic disease and vaccination granulomas: A nested case-control studyStine Skovbo Hoffmann, Emilia Myrup Thiesson, Jeanne Duus Johansen, et al.
Contact Dermatitis|July 2, 2022
Risk factors for granulomas in children following immunization with aluminium-adsorbed vaccines: A Danish population-based cohort studyStine Skovbo Hoffmann, Emilia Myrup Thiesson, Jeanne Duus Johansen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 23, 2023
SARS-CoV-2 Infection and Postacute Risk of Non-Coronavirus Disease 2019 Infectious Disease Hospitalizations: A Nationwide Cohort Study of Danish Adults Aged ≥50 YearsNiklas Worm Andersson, Emilia Myrup Thiesson, Ria Lassaunière, et al.
Journal of Inflammation Research|November 11, 2024
Inflammatory Risk Factors for Chronic Subdural Hematoma in a Nationwide CohortThorbjørn Søren Rønn Jensen, Emilia Myrup Thiesson, Kåre Fugleholm, et al.
BMJ (Clinical Research Ed.)|July 13, 2022
Safety of heterologous primary and booster schedules with ChAdOx1-S and BNT162b2 or mRNA-1273 vaccines: nationwide cohort studyNiklas Worm Andersson, Emilia Myrup Thiesson, Mona Vestergaard Laursen, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|February 27, 2026
Feasibility of conducting brand-specific influenza vaccine effectiveness studies in three Nordic countries, Denmark, Finland, SwedenKristyna Faksova, Emilia Myrup Thiesson, Nicklas Pihlström, et al.
The Lancet Regional Health. Europe|November 19, 2025
Brand-specific influenza vaccine effectiveness in three Nordic countries during the 2024-2025 season: a target trial emulation study based on registry dataKristyna Faksova, Emilia Myrup Thiesson, Nicklas Pihlström, et al.
Pageof 2